Anebulo Pharmaceuticals Stock Performance
| ANEB Stock | USD 0.47 0.01 2.08% |
The firm shows a Beta (market volatility) of -1.9, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Anebulo Pharmaceuticals are expected to decrease by larger amounts. On the other hand, during market turmoil, Anebulo Pharmaceuticals is expected to outperform it. At this point, Anebulo Pharmaceuticals has a negative expected return of -2.14%. Please make sure to confirm Anebulo Pharmaceuticals' coefficient of variation, total risk alpha, skewness, as well as the relationship between the information ratio and maximum drawdown , to decide if Anebulo Pharmaceuticals performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Anebulo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain somewhat strong which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
1 | Will Anebulo Pharmaceuticals Inc. stock deliver strong dividend growth - 2025 Price Action Summary Low Drawdown Trading Strategies - newser.com | 11/18/2025 |
2 | Will Anebulo Pharmaceuticals Inc. stock pay special dividends - 2025 Winners Losers Free Reliable Trade Execution Plans - | 12/18/2025 |
3 | Anebulo Pharmaceuticals Announces Its Intent to Commence a Self Tender Offer | 12/22/2025 |
4 | 12 Health Care Stocks Moving In Mondays After-Market Session - Benzinga | 12/29/2025 |
5 | Why retail investors pile into Anebulo Pharmaceuticals Inc. stock - High Beta Stocks High Return Trading Tips - ulpravda.ru | 01/07/2026 |
6 | Meme Stocks Will Anebulo Pharmaceuticals Inc stock maintain momentum in 2025 - July 2025 Highlights Weekly Stock Breakout Alerts - moha.gov.vn | 01/13/2026 |
7 | Anebulo Pharmaceuticals Announces Preliminary Results of Tender Offer | 01/27/2026 |
8 | Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC | 02/06/2026 |
Anebulo Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 228.00 in Anebulo Pharmaceuticals on November 14, 2025 and sell it today you would lose (181.00) from holding Anebulo Pharmaceuticals or give up 79.39% of portfolio value over 90 days. Anebulo Pharmaceuticals is currently does not generate positive expected returns and assumes 8.4586% risk (volatility on return distribution) over the 90 days horizon. In different words, 75% of stocks are less volatile than Anebulo, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Anebulo Pharmaceuticals Target Price Odds to finish over Current Price
The tendency of Anebulo Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.47 | 90 days | 0.47 | over 95.46 |
Based on a normal probability distribution, the odds of Anebulo Pharmaceuticals to move above the current price in 90 days from now is over 95.46 (This Anebulo Pharmaceuticals probability density function shows the probability of Anebulo Stock to fall within a particular range of prices over 90 days) .
Anebulo Pharmaceuticals Price Density |
| Price |
Predictive Modules for Anebulo Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Anebulo Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Anebulo Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Anebulo Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Anebulo Pharmaceuticals is not an exception. The market had few large corrections towards the Anebulo Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Anebulo Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Anebulo Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.95 | |
β | Beta against Dow Jones | -1.9 | |
σ | Overall volatility | 0.68 | |
Ir | Information ratio | -0.27 |
Anebulo Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Anebulo Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Anebulo Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Anebulo Pharmaceuticals generated a negative expected return over the last 90 days | |
| Anebulo Pharmaceuticals has high historical volatility and very poor performance | |
| Anebulo Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (8.48 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Anebulo Pharmaceuticals currently holds about 14.55 M in cash with (6.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.62, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Anebulo Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Roughly 41.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC |
Anebulo Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Anebulo Stock often depends not only on the future outlook of the current and potential Anebulo Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Anebulo Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 33.8 M | |
| Cash And Short Term Investments | 11.6 M |
Anebulo Pharmaceuticals Fundamentals Growth
Anebulo Stock prices reflect investors' perceptions of the future prospects and financial health of Anebulo Pharmaceuticals, and Anebulo Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Anebulo Stock performance.
| Return On Equity | -1.45 | ||||
| Return On Asset | -0.86 | ||||
| Current Valuation | 9.06 M | ||||
| Shares Outstanding | 40.78 M | ||||
| Price To Book | 2.01 X | ||||
| EBITDA | (8.1 M) | ||||
| Net Income | (8.48 M) | ||||
| Cash And Equivalents | 14.55 M | ||||
| Cash Per Share | 0.62 X | ||||
| Total Debt | 487.69 K | ||||
| Current Ratio | 30.40 X | ||||
| Book Value Per Share | 0.24 X | ||||
| Cash Flow From Operations | (6.35 M) | ||||
| Earnings Per Share | (0.22) X | ||||
| Market Capitalization | 19.41 M | ||||
| Total Asset | 12.15 M | ||||
| Retained Earnings | (73.89 M) | ||||
| Working Capital | 11.47 M | ||||
About Anebulo Pharmaceuticals Performance
By analyzing Anebulo Pharmaceuticals' fundamental ratios, stakeholders can gain valuable insights into Anebulo Pharmaceuticals' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Anebulo Pharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Anebulo Pharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.80) | (0.84) | |
| Return On Capital Employed | (0.89) | (0.93) | |
| Return On Assets | (0.80) | (0.84) | |
| Return On Equity | (0.84) | (0.88) |
Things to note about Anebulo Pharmaceuticals performance evaluation
Checking the ongoing alerts about Anebulo Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Anebulo Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Anebulo Pharmaceuticals generated a negative expected return over the last 90 days | |
| Anebulo Pharmaceuticals has high historical volatility and very poor performance | |
| Anebulo Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (8.48 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Anebulo Pharmaceuticals currently holds about 14.55 M in cash with (6.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.62, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Anebulo Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Roughly 41.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC |
- Analyzing Anebulo Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Anebulo Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Anebulo Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Anebulo Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Anebulo Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Anebulo Pharmaceuticals' stock. These opinions can provide insight into Anebulo Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Anebulo Stock analysis
When running Anebulo Pharmaceuticals' price analysis, check to measure Anebulo Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anebulo Pharmaceuticals is operating at the current time. Most of Anebulo Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Anebulo Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anebulo Pharmaceuticals' price. Additionally, you may evaluate how the addition of Anebulo Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |